Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανάλυση πληθυσμιακής φαρμακοκινητικής της τεϊκοπλανίνης σε νεογνά με ενδονοσοκομειακές λοιμώξεις

Abstract

dc:description

Our objective was to develop a population pharmacokinetic (PK) model in order to evaluate the currently recommended dosing regimen in term and preterm neonates. By using an optimal design approach, a prospective PK study was designed and implemented in 60 neonates with postmenstrual age (PMA) of 26 to 43 weeks. A loading dose of 16 mg/kg was administered at day 1, followed by a maintenance dose of 8 mg/kg daily. Plasma concentrations were quantified by high pressure liquid chromatography–mass spectrometry. Population PK (popPK) analysis was performed using NONMEM software. Monte-Carlo (MC) simulations were performed to evaluate currently recommended dosing based on a pharmacodynamic index of area under the concentration-time curve (AUC)/MIC ratio of ≥ 400. A two compartment model with linear elimination best described the data by the following equations: CL (clearance)=0.0227* (WT/1765)^0.75*(eCRCL/22)^0.672, V1 (central compartment volume)=0.283*(WT/1765), Q (intercompartmental clearance)=0.151*(WT/1765)^0.75, V2 (peripheral compartment volume)=0.541*(WT/1765). The interindividual variability estimates for CL, V1, and V2 were 36.5%, 45.7%, and 51.4%, respectively. Current weight (WT) and estimated creatinine clearance (eCRCL) significantly explained the observed variability. MC simulation demonstrated that, with the current dosing regimen, an AUC/MIC ratio of ≥ 400 was reached by only 68.5% of neonates with WT of <1 kg when the MIC was equal to 1 mg/l, versus 82.2%, 89.7%, and 92.7% of neonates with wt of 1 to <2, 2 to <3, or ≥ 3 kg, respectively. Augmentation of a maintenance dose up to 10 or 11 mg/kg for preterm neonates with wt of 1 to <2 or <1 kg, respectively, increases the probability of reaching the therapeutic target; the recommended doses seem to be adequate for neonates with WT of ≥ 2 kg. Teicoplanin PK is variable in neonates, with WT and eCRCL having the most significant impact. Neonates with WT of <2 kg need higher doses, especially for Staphylococcus spp. withan MIC value of ≥ 1 mg/l.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kontou, Angeliki
  • Κοντού, Αγγελική

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47532

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kontou, Angeliki; Κοντού, Αγγελική. Ανάλυση πληθυσμιακής φαρμακοκινητικής της τεϊκοπλανίνης σε νεογνά με ενδονοσοκομειακές λοιμώξεις. Aristotle University Of Thessaloniki (AUTH), 2020. http://hdl.handle.net/10442/hedi/47532